Branded

Cequa is the first and only FDA approved cyclosporine treatment delivered with nanomicellar, or NCELL technology.

Eli Lilly's Reyvow is a new option for the acute treatment of migraine.

Roche's Rituxan now is the first and only FDA approved treatment for pediatric patients 2 years of age and older living with granulomatosis with polyangiitis or microscopic polyangiitis.

SB 159 authorizes pharmacists to prescribe PrEP and PEP to patient without a physician prescription and prohibits insurance companies from requiring patients to obtain prior authorization before using their insurance benefits to obtain PrEP or PEP.

Galderma's Aklief (trifarotene cream) is the first new retinoid molecule to receive FDA approval for the treatment of acne in more than 20 years

AstraZeneca's Fasenra is the only respiratory biologic that offers the choice of administration at home or in a doctor’s office with eight-week maintenance dosing, the company said.

Descovy is the second FDA approved to prevent HIV infection.

Mavyret is now the first eight-week treatment approved for all treatment-naïve adult and certain pediatric patients with HCV genotypes 1-6 both without cirrhosis and with compensated cirrhosis.